| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.009 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.01 |